68-7-1 to 68-7-6 (Authorized by K.S.A. 1975 Supp. 65-1630; effective Jan. 1, 1968; revoked, E-76-31,
Aug. 11, 1975; revoked May 1, 1976.)
68-7-7 (Authorized by K.S.A. 1977 Supp. 65-1630; effective, E-76-31, Aug. 11, 1975; effective May
1, 1976; revoked May 1, 1978.)
68-7-8 Records. Original written prescriptions shall be deemed recordation in writing by the
pharmacist under the provisions of K.S.A. 65-1637 (b) (1975 Supp.). (Authorized by K.S.A. 1975
Supp. 65-1630; effective, E-76-31, Aug. 11, 1975; effective May 1, 1976.)
68-7-9 (Authorized by K.S.A. 1977 Supp. 74-1606; effective, E-76-31, Aug. 11, 1975; effective May
1, 1976; amended May 1, 1978; revoked May 1, 1987.)
68-7-10 Pharmacy based drug distribution systems in adult care homes; definitions; emergency medication kits.
(a) Definitions.
(1) ‘‘Adult care home’’ has the same meaningas set forth in K.S.A. 39-923.
(2) ‘‘Unit dose system’’ means a drug distribution system which is pharmacy-based and which uses unit dose containers that enable distribution of packaged doses in a manner that preserves the identity of the drug until the time of administration.
(3) ‘‘Traditional system’’ means a drug distribution system in which the pharmacist receives a prescription order for an individual patient and fills the prescription in any manner other than
packaging individual doses in unit dose containers.
(4) ‘‘Unit dose container’’ means a single or multiple unit container for articles intended for
administration in single doses, directly from the container, by other than parenteral route.
(A) ‘‘Multiple unit container’’ means a container that permits withdrawal of successive portions of the contents without changing the strength, quality, or purity of the remaining portion.
(B) ‘‘Single unit container’’ means a container that is designed to hold a quantity of a drug intended for administration as a single dose promptly after the container is opened.
(b) All pharmacy-based drug distribution systems for adult care homes shall:
(1) Be consistent with the medication needs of the patient;
(2) conform to all federal and state laws and regulations pertaining to pharmacies; and
(3) conform to the following additional requirements:
(A) All prescriptions (unit dose or traditional) shall be dispensed from a pharmacy within a reasonable length of time after the medication is ordered.
(B) The supplying pharmacy shall be responsible for the safe delivery of drugs to a designated person or persons in the adult care home.
(C) The supplying pharmacy shall provide a method of identifying the date and quantity of medication dispensed.
(D) A patient medication profile record system shall be maintained for each adult care home patient serviced by the supplying pharmacy and shall contain the information necessary to allow the pharmacist to monitor each patient’s drug therapy.
(E) All medication distribution system containers shall be labeled to permit the identification of the drug therapy.
(c) All unit dose drug distribution systems shall, in addition to the above requirements, con-
form to the following requirements:
(1) All medication shall be packaged in unit dose containers as far as practicable, and the packaging shall conform to the provisions of K.A.R. 68-7-15 and 68-7-16.
(2) The pharmacist shall be responsible for filling and refilling prescriptions or practitioner’s orders or both according to the directions of the practitioner by relying on the original prescription or practitioner’s order or a direct copy thereof.
(3) The pharmacist shall comply with all requirements for prescription orders, including
inventory and record keeping requirements, under:
(A) The Kansas uniform controlled substances act, K.S.A. 65-4101 et seq.;
(B) the Kansas pharmacy act, K.S.A. 65-1601et seq.;
(C) the applicable regulations in K.A.R. 68-20-1 et seq. and K.A.R. 68-1-1 et seq.; and
(D) all federal laws and regulations applicable to prescriptions or medication orders.
(4) Unit dose dispensing shall take place at the address of the pharmacy providing the unit dose system.
(5) Container requirements for unit-dose distribution systems may include trays, bins, carts
and locked cabinets if the requirements of K.A.R. 68-7-14 are complied with. If these options are
used, all patient medication trays or drawers shall be sufficiently labeled to identify the patient.
(6) Each unit dose distribution system shall provide a verification check at the point of patient administration in order to insure proper drug utilization.
(7) The delivery time-cycle or hours of exchange shall not be limited to a specific time, but shall depend upon the pharmacist’s discretion, the needs of the adult care home, the stability of
the drug, and the type of container used.
(8) The pharmacist or a pharmacy intern under the direct supervision of a pharmacist shall have sole responsibility for dispensing under the unit dose system.
(d) Emergency medication kits.
(1) Emergency medication kits shall contain only the drugs which are generally regarded by practitioners as essential to the prompt treatment of sudden and unforeseen changes in a patient’s condition which present an imminent threat to the patient’s life or well-being.
(2) Drugs to be contained within emergency medication kits shall be approved by the adult care home pharmaceutical services committee (or its equivalent) composed of at least a practitioner and a pharmacist.
(3) The emergency medication kit shall conform to the following requirements:
(A) The kit shall be supplied by a pharmacist who shall retain possession of the drug until it is administered to the patient upon the proper order of a practitioner.
(B) The kit shall be locked or sealed in a manner that obviously reveals when the kit has been opened or tampered with.
(C) The kit shall be securely locked in a sufficiently well-constructed cabinet or cart and access to the cabinet or cart shall be available only to the nurse or nurses as determined by the pharmaceutical services committee or its equivalent.
(D) The kit shall have an expiration date equivalent to the earliest expiration date of drugs within the kit, but in no event more than one year after all of the drugs were placed in the kit.
(E) All drugs contained within the emergency medication kit shall be returned to the pharmacy as soon as the kit is opened, along with the practitioner’s drug order for medications administered.
(Authorized by and implementing K.S.A. 65-1648; effective May 1, 1978; amended May 1,1983; amended Sept. 9, 1991.)
68-7-11. Medical care facility pharmacy. The scope of pharmaceutical services within a medical care
facility pharmacy shall conform to the following requirements:
(a) The pharmacist-in-charge shall be responsible for developing programs and supervising all
personnel in the distribution and control of drugs and all pharmaceutical services in the medical care
facility.
(b) The pharmacist-in-charge shall develop a policy and procedure manual governing the storage,
control, and distribution of drugs within the medical care facility. The pharmacist-in-charge shall
submit the policy and procedure manual for approval to the pharmacy and therapeutics committee or
an equivalent committee governing the security, control, and distribution of drugs within the facility.
(c) The pharmacist-in-charge shall be responsible for the maintenance of all emergency medication
kits.
(d) The pharmacist-in-charge shall be responsible for developing procedures for the distribution and
control of drugs within the medical care facility when a pharmacist is not on the premises. These
procedures shall be consistent with the following requirements:
(1) Inpatient service. Drugs may be obtained upon a prescriber’s medication order for administration
to the inpatient by a designated registered professional nurse or nurses with approval and supervision
of the pharmacist-in-charge. Adequate records of these withdrawals shall be maintained.
(2) Emergency outpatient service.
(A) An interim supply of prepackaged drugs shall be supplied to an outpatient only by a designated registered professional nurse or nurses pursuant to a prescriber’s medication order when a
pharmacist is not on the premises and a prescription cannot be filled. The interim supply shall be
labeled with the following information:
(i) The name, address, and telephone number of the medical care facility;
(ii) the name of the prescriber. The label shall include the name of the practitioner and, if
involved, the name of either the physician’s assistant (PA) or the advanced registered nurse
practitioner (ARNP);
(iii) the full name of the patient;
(iv) the identification number assigned to the interim supply of the drug or device by the
medical care facility pharmacy;
(v) the date the interim supply was supplied;
(vi) adequate directions for use of the drug or device;
(vii) the beyond-use date of the drug or device issued;
(viii) the brand name or corresponding generic name of the drug or device;
(ix) the name of the manufacturer or distributor of the drug or device, or an easily identified
abbreviation of the manufacturer’s or distributor’s name;
(x) the strength of the drug;
(xi) the contents in terms of weight, measure, or numerical count; and
(xii) necessary auxiliary labels and storage instruction, if needed.
(B) The interim supply shall be limited in quantity to an amount sufficient to supply the
outpatient’s needs until a prescription can be filled. Adequate records of the distribution of the interim
supply shall be maintained and shall include the following information:
(i) The original or a copy of the prescriber’s order, or if an oral order, a written record prepared
by a designated registered professional nurse or nurses that reduces the oral order to writing. The written record shall be signed by the designated registered professional nurse or nurses and the
(ii) the name of the patient; the date supplied; the drug or device, strength, and quantity
distributed; directions for use; the prescriber’s name; and, if appropriate, the DEA number.
(3) The designated registered professional nurse or nurses may enter the medical care facility
pharmacy and remove properly labeled pharmacy stock containers, commercially labeled packages, or
properly labeled prepackaged units of drugs. The registered professional nurse shall not transfer a drug
from one container to another for future use, but may transfer a single dose from a stock container for
immediate administration to the ultimate user.
(e) The pharmacist-in-charge of the medical care facility pharmacy shall maintain documentation of at
least quarterly checks of drug records and conditions of drug storage, in all locations within the
facility, including nursing stations, emergency rooms, outpatient departments, and operating suites.
(f) The pharmacist-in-charge shall participate with the pharmacy and therapeutics committee or an
equivalent committee in formulating broad professional policies regarding the evaluation, appraisal,
selection, procurement, storage, distribution, use, and safety procedures for drugs within the medical
care facility.
(g) The pharmacist-in-charge shall be responsible for establishing a drug recall procedure that can be
effectively implemented.
(h) (1) The pharmacist-in-charge shall be responsible for developing written procedures for maintainingrecords of drug distribution, prepackaging, and bulk compounding. Prepackaged drugs shall include
the following information:
(A) The brand name or corresponding generic name of the drug;
(B) the name of the manufacturer or distributor of the drug, or an easily identified abbreviation
of the manufacturer’s or distributor’s name;
(C) the strength of the drug;
(D) the contents in terms of weight, measure, or numerical count;
(E) the lot number; and
(F) the beyond-use date.
(2) Prepackaged drugs shall be packaged in suitable containers and shall be subject to all other
provisions of the Kansas state board of pharmacy regulations under the uniform controlled substances
act of the state of Kansas and under the pharmacy act of the state of Kansas. Before releasing any
drugs or devices from the pharmacy, the pharmacist shall verify the accuracy of all prepackaging and
the compounding of topical and oral drugs.
(i) The pharmacist-in-charge shall ensure that the medical care facility maintains adequate drug
information references commensurate with services offered and a current copy of the Kansas pharmacy
act, the Kansas uniform controlled substances act, and current regulations under both acts.
(j) The pharmacist-in-charge shall be responsible for pharmacist supervision of all pharmacy
technicians and for confining their activities to those functions permitted by the pharmacy practice act.
Records shall be maintained describing the following:
(1) The training and related education for nondiscretionary tasks performed by pharmacy
technicians; and
(2) written procedures designating the person or persons functioning as pharmacy technicians,
describing the functions of the pharmacy technicians, and documenting
the procedural steps taken by the pharmacist-in-charge to limit the functions of pharmacy technicians
to nondiscretionary tasks.
(k) The pharmacist-in-charge shall be responsible for establishing policies and procedures for the
mixing or preparation of parenteral admixtures. Whenever drugs are added to intravenous solutions,
distinctive supplemental labels shall be affixed that indicate the name and amount of the drug added,
the date and the time of addition, the beyond-use date, storage instructions, and the name or initials of
the person who prepared the admixture. The pharmacist-in-charge shall comply with all requirements
of K.A.R. 68-13-1. Before the parenteral admixture is released from the pharmacy, the pharmacist
shall verify the accuracy of all parenteral admixtures prepared by pharmacy technicians.
(l) The pharmacist shall interpret the prescriber’s original order, or a direct copy of it, before the drug
is distributed and shall verify that the medication order is filled in strict conformity with the direction
of the prescriber. This requirement shall not preclude orders transmitted by the prescriber through
electronic transmission. Variations in this procedure with ‘‘after-the-fact’’ review of the prescriber’s
original order shall be consistent with medical care facility procedures established by the pharmacistin-
charge. Each medication order shall be reviewed by a pharmacist within seven days of the date it
was written.
(m) Pharmacy services to outpatients during pharmacy hours shall be in accordance with the board’s
regulations, K.S.A. 65-1625 et seq., and K.S.A. 65-4101 et seq., and amendments thereto, governing
community pharmacy practice.
(n) The pharmacist-in-charge shall be responsible for the security of the pharmacy, including the drug
distribution systems and personnel.
(1) When a pharmacist is on the premises but not in the pharmacy, a pharmacy technician may be in
the pharmacy. A pharmacy technician shall not distribute any drug or device out of the pharmacy when
a pharmacist is not physically in the pharmacy unless authorized by the pharmacist.
(2) When a pharmacist is not on the premises, no one shall be permitted in the pharmacy except the
designated registered professional nurse or nurses.
(o) Each pharmacist-in-charge who will no longer be performing the functions of the pharmacist-incharge
position shall inventory all controlled substances in the pharmacy before leaving the
pharmacist-in-charge position. A record of the inventory shall be maintained for at least five years.
(p) Within 72 hours after beginning to function as a pharmacist-in-charge, the pharmacist-in-charge
shall inventory all controlled substances in the pharmacy. A record of the inventory shall be
maintained for at least five years.
(q) Except with regard to drugs that have not been checked for accuracy by a pharmacist after having
been repackaged, prepackaged, or compounded in a medical care facility pharmacy, a pharmacy
technician in a medical care facility may check the work of another pharmacy technician in filled floor
stock, a crash cart tray, a unit dose cart, or an automated dispensing machine if the checking pharmacy
technician meets each of the following criteria:
(1) Has a current certification issued by the pharmacy technician certification board or a current
certification issued by any other pharmacy technician certification organization approved by the board.
Any pharmacy technician certification organization may be approved by the board if the board
determines that the organization has a standard for pharmacy technician certification and recertification
not below that of the pharmacy technician certification board;
(2) has either of the following experience levels:
(A) One year of experience working as a pharmacy technician plus at least six months experience
working as a pharmacy technician in the medical care facility at which the checking will be performed;
or
(B) one year of experience working as a pharmacy technician in the medical care facility at which
the checking will be performed; and
(3) has successfully completed a written training program and related examination designed by the
pharmacist-in-charge of the medical care facility pharmacy to demonstrate competency in accurately
checking whether floor stock, a crash cart tray, and an automated dispensing machine have been
properly filled.
(Authorized by K.S.A. 65-1630; implementing K.S.A. 2008 Supp. 65-1626, K.S.A. 2008 Supp. 65-
1642, and K.S.A. 65-1648; effective, E-77-39, July 22, 1976; effective Feb. 15, 1977; amended May 1,
1978; amended May 1, 1988; amended May 1, 1989; amended Dec. 27, 1999; amended April 28,
2000; amended July 20, 2007; amended July 16, 2010.)
68-7-12 Responsibility of pharmacist-in-charge in other than a medical care facility pharmacy.
Each pharmacist-in-charge for premises having a pharmacy registration, other than a medical care
facility pharmacy, shall be responsible for the following functions.
(a) Each pharmacist-in-charge shall develop, supervise, and coordinate all pharmaceutical services
carried on within the pharmacy to ensure compliance with the Kansas pharmacy act, the Kansas
uniform controlled substances act, federal drug laws, and all applicable regulations.
(b) Each pharmacist-in-charge shall be personally available to the extent required to ensure
comprehensive pharmaceutical services within the pharmacy and to develop a staff of additional
licensed pharmacists and supportive personnel as necessary to serve the needs of the pharmacy. Each
pharmacist-in-charge shall maintain records in the pharmacy describing the training and education
regarding work functions performed by all pharmacy personnel. Each pharmacist-in-charge shall
maintain in the pharmacy written procedures that address the following areas:
(1) Designate the person or persons functioning as pharmacy technicians and supportive personnel;
(2) describe the functions of all personnel; and
(3) document the procedural steps taken by the pharmacist-in-charge to limit the functions of all
personnel to their respective pharmacy work functions.
(c) Each pharmacist-in-charge shall develop or approve written policies and procedures for the
pharmacy that meet all of the following conditions:
(1) Adequate accountability and control of drugs in compliance with the Kansas pharmacy act, the
Kansas uniform controlled substances act, federal drug laws, and all applicable regulations are
provided for.
(2) Any incident that occurs as a result of an alleged or real error in filling or dispensing a
prescription or medication order is brought to the attention of the pharmacist-in-charge and completely
documented in accordance with the requirements of K.A.R. 68-7-12b.
(3) Adequate records of the pharmacy's dispensing, prepackaging, and bulk compounding actions
are maintained, and all prepackaging of drugs is done in suitable containers, properly labeled in
accordance with K.A.R. 68-7-16.
(d) Each pharmacist-in-charge shall develop written procedures for maintaining records of the
pharmacy's dispensing, prepackaging, and bulk compounding actions and shall ensure that
prepackaged medication is packaged in suitable containers and properly labeled.
(e) A pharmacist-in-charge who will no longer be performing the functions of the pharmacist-in-charge
position shall inventory all controlled substances in the pharmacy before leaving the pharmacist-incharge
position. A record of the inventory shall be maintained for at least five years.
(f) Within 72 hours after beginning to function as a pharmacist-in-charge, the pharmacist-in-charge
shall inventory all controlled substances in the pharmacy. A record of the inventory shall be
maintained for at least five years.
(Authorized by K.S.A. 65-1630 and K.S.A. 2006 Supp. 65-1643; implementing K.S.A. 2006 Supp. 65-
1626 and K.S.A. 2006 Supp. 65-1637; effective, E-77-39, July 22, 1976; effective Feb. 15, 1977;
amended May 1, 1978; amended May 1, 1989; amended Nov. 30, 1992; amended Feb. 27, 1998;
amended Dec. 27, 1999; amended Feb. 7, 2003; amended July 20, 2007.)
68-7-12a Nonresident pharmacies. (a) Nonresident pharmacies shall meet the following requirements
to be and remain registered in Kansas by the board.
(1) Each pharmacy shall be currently licensed or registered in good standing in the state in which it
is located.
(2) Each pharmacist dispensing drugs into Kansas shall be licensed as a pharmacist in the state
where the pharmacist practices.
(b) A pharmacist licensed in the state where the pharmacist practices shall be named in the application
as the pharmacy's responsible pharmacist, who shall be responsible for receiving communications from
the board.
(1) That pharmacist shall timely respond to any lawful request for information from the board or law
enforcement authorities.
(2) That pharmacist shall be responsible for receiving and maintaining publications distributed by
the board.
(3) If at any time the pharmacist so designated leaves the employment of the pharmacy, the owner or
the owner's authorized representative of the pharmacy shall promptly notify the board and designate
another pharmacist to perform this function.
(c) The owner or the owner's authorized representative of the nonresident pharmacy shall apply for
registration and renewal on forms approved by the board. The information reasonably necessary to
carry out the provisions of K.S.A. 65-1657 and amendments thereto, including the name, address, and
position of each officer and director of a corporation or of the owners if the pharmacy is not a
corporation, may be required by the board.
(d) An exemption for registration may be granted by the board under K.S.A. 65-1657 and amendments
thereto, upon application by any nonresident pharmacy that confines its dispensing activity to isolated
transactions. The following shall be considered to determine whether to grant an exemption:
(1) The number of prescriptions dispensed or reasonably expected to be dispensed into Kansas;
(2) the number of patients served or reasonably expected to be served in Kansas;
(3) any efforts to promote the pharmacy's services in Kansas;
(4) any contract between the pharmacy and either an employer or organization to provide pharmacy
services to employees or other beneficiaries in Kansas;
(5) medical necessity;
(6) the effect on the health and welfare of persons in Kansas; and
(7) any other relevant matters.
(e) The pharmacy owner shall pay an annual registration fee as set forth in K.A.R. 68-11-2.
(f) The pharmacy records of drugs dispensed to Kansas addresses shall be maintained so that the
records are readily retrievable upon request. These records shall be made available for inspection by
the board or by Kansas law enforcement authorities upon request.
(g) The pharmacy shall maintain an incoming toll-free telephone number for use by Kansas customers
to facilitate personal communication with a pharmacist with access to patient records.
(1) This service shall be available during normal business hours for a minimum of 40 hours and six
days per week.
(2) This telephone number and any others available for use shall be printed on each container of
drugs dispensed in Kansas.
(3) The toll-free number shall have a sufficient number of extensions to provide reasonable access to
incoming callers.
(h) Generic drugs shall be dispensed into Kansas only pursuant to K.S.A. 65- 1637(a), and
amendments thereto.
(i) The facilities and records of the pharmacy shall be subject to inspection by the board. Satisfactory
inspection reports by the licensing entity using similar standards of the state where the pharmacy is
located may be accepted in lieu of inspection by the board.
(j) Each owner or owner's authorized representative of the nonresident pharmacy doing business in
Kansas by dispensing and either delivering or causing to be delivered prescription drugs to Kansas
consumers shall designate a resident agent in Kansas for service of process and file this information
with the secretary of state.
(Authorized by and implementing K.S.A. 2001 Supp. 65-1657; effective March 29, 1993; amended
March 20, 1995; amended Feb. 7, 2003.)
68-7-12b Incident reports. (a) For purposes of this regulation, "reportable incident" and "incident"
shall mean a preventable medication error involving a prescription drug and resulting in any of the
following:
(1) The patient receiving the wrong drug;
(2) the patient receiving an incorrect drug strength
(3) the patient receiving an incorrect dosage form;
(4) the drug being received by the wrong patient;
(5) inadequate or incorrect packaging, labeling, or directions; or
(6) the dispensing of a drug to a patient in a situation that results in or has the potential to result in
serious harm to the patient.
(b) For each pharmacy other than a medical care pharmacy, the pharmacist-in-charge shall ensure that
procedures exist requiring each pharmacist who becomes aware of a reportable incident to report the
incident to the pharmacist-in-charge as soon as practical.
(c) As soon as possible after discovery of the incident, the pharmacist shall prepare a report containing
the following information:
(1) The name, address, age, and phone number of any complainant, if available;
(2) the name of each pharmacy employee and the license number of each licensee involved;
(3) the date of the incident and the date of the report;
(4) a pharmacist's description of the incident;
(5) the prescriber's name and whether or not the prescriber was contacted; and
(6) the signatures of all pharmacy employees involved in the incident.
For each pharmacy, the pharmacist-in-charge shall ensure that procedures exist requiring that the
incident report be maintained in the pharmacy for at least five years in a manner so that the report can
be provided to the board or its representative within three business days, upon request.
(d) The preparation of an incident report that meets the requirements of this regulation shall be the
responsibility of each pharmacist involved in the incident and the pharmacist-in-charge. The
maintenance of incident reports as required by this regulation shall be the responsibility of the
pharmacist-in-charge.
(Authorized by K.S.A. 65-1630; implementing K.S.A. 2007 Supp. 65-1626 and K.S.A. 2007 Supp. 65-
1626d; effective Feb. 7, 2003; amended Oct. 24, 2008.)
68-7-13 Pharmacist in charge of more than one location. No pharmacist shall be a pharmacist in
charge of more than one full-time pharmacy operation, which is defined as being one where the onpremises
pharmacist services total 30 hours or more weekly. (Authorized by and implementing K.S.A.
65-1630; effective, E-77-39, July 22, 1976; effective Feb. 15, 1977; amended May 1, 1988.)
68-7-14 Prescription labels. (a) The label of each drug or device shall be typed or machine-printed
and shall include the following information:
(1) The name, address, and telephone number of the pharmacy dispensing the prescription;
(2) the name of the prescriber;
(3) the full name of the patient;
(4) the identification number assigned to the prescription by the dispensing pharmacy;
(5) the date the prescription was filled or refilled;
(6) adequate directions for use of the drug or device;
(7) the beyond-use date of the drug or device dispensed;
(8) the brand name or corresponding generic name of the drug or device;
(9) the name of the manufacturer or distributor of the drug or device, or an easily identified
abbreviation of the manufacturer's or distributor's name;
(10) the strength of the drug;
(11) the contents in terms of weight, measure, or numerical count; and
(12) necessary auxiliary labels and storage instructions, if needed.
(b) A pharmacy shall be permitted to label or relabel only those drugs or devices originally dispensed
from the providing pharmacy.
(Authorized by K.S.A. 65-1630; implementing K.S.A. 65-1626a; effective, E-77-39, July 22, 1976;
effective Feb. 15, 1977; amended May 1, 1978; amended May 1, 1980; amended May 1, 1988;
amended June 6, 1994; amended March 20, 1995; amended April 28, 2000; amended Oct. 23, 2009.)
68-7-15 Prepackaging or repackaging of drugs. All prepackaging or repackaging of drugs, whether
in a unit dose container or multiple dose container shall conform to the following:
(a) Packaging in advance of immediate need shall be done by a pharmacist or under his or her direct
supervision.
(b) This packaging shall be limited to drugs to be dispensed from the premises.
(c) Proper storage conditions shall be maintained so as to preserve the stability of the drug as
recommended by the manufacturer.
(d) A proper control system shall be established for lot numbers for recall purposes.
(e) If an area apart or separated from the prescription area is used for prepackaging or repackaging,
such area must be enclosed and secured (locked) when a pharmacist is not in attendance in that area.
(Authorized by K.S.A. 1977 Supp. 65-1630; effective May 1, 1978.)
68-7-16 Labels for prepackaged or repackaged drugs. Labels for prepackaged and repackaged
drugs shall contain the following:
(a) The generic name with manufacturer and distributor's name or the brand name.
(b) Strength and quantity.
(c) Lot number and date repackaged and the person responsible for packaging.
(d) The expiration date, if applicable.
(e) Auxiliary labels necessary.
(f) Manufacturer, lot numbers, date repackaged, and the person responsible may be deleted from the
label if a suitable record system is maintained to indicate them.
(Authorized by K.S.A. 1977 Supp. 65-1630; effective May 1, 1978.)
68-7-17 (Authorized by K.S.A. 1977 Supp. 65-1630; effective Feb. 15, 1977; revoked May 1, 1978.)
68-7-18 Health departments and private not-for-profit family planning clinics. The distribution
and control of drugs provided by health departments and private not-for-profit family planning clinics
authorized under K.S.A. 65- 1648(d)(1), and amendments thereto, shall conform to the following
requirements:
(a) The approved drugs that may be stored and distributed by health departments and not-for-profit
family planning clinics shall be only noncontrolled drugs that are approved by the food and drug
administration. In determining the formulary for each health department or not-for-profit family
planning clinic, the pharmacist-in-charge shall consult with the medical supervisor and director of
nursing for that facility. No state or federal controlled drugs shall be allowed.
(b) (1) The pharmacist-in-charge shall review the procedures outlined below for the distribution and control of all drugs within health department facilities and family planning clinics and shall be responsible for the following:
(A) Ensuring the development of programs for supervision of all personnel in the distribution and
control of drugs;
(B) ensuring the development of a policy and procedure manual governing the storage, control,
and distribution of drugs;
(C) maintaining documentation of at least quarterly checks of drug records, drug storage
conditions, and drugs stored in all locations within the facility;
(D) establishing a drug recall procedure that can be effectively implemented; and
(E) ensuring the development of written procedures for maintaining records of distribution and
prepackaging of drugs.
(2) Labels for prepackaged drugs shall contain the following:
(A) The brand name or corresponding generic name of the drug;
(B) the name of the manufacturer or distributor of the drug, or an easily identified abbreviation of
the manufacturer's or distributor's name;
(C) the strength of the drug;
(D) the contents in terms of weight, measure, or numerical count;
(E) the lot number of the drug, if the lot number is not recorded on a suitable log; and
(F) the beyond-use date of the drug.
(3) Prepackaged drugs shall be packaged in suitable containers and shall be subject to all other
provisions of the Kansas state board of pharmacy regulations under the uniform controlled substances
act of the state of Kansas and under the pharmacy act of the state of Kansas.
(c) The procedures for the control and distribution of drugs within health department facilities and
family planning clinics shall be consistent with the following requirements:
(1) Adequate records of the distribution of drugs by the designated registered professional nurse or
nurses shall be maintained and shall include the physician's order or written protocol.
(A) If the physician's order was given orally, electronically, or by telephone, the designated registered professional nurse or nurses shall reduce that order to writing. The written copy of the order shall be signed by the designated registered professional nurse and maintained in a permanent patient
file.
(B) The records shall include the following:
(i) The full name of the patient;
(ii) the date supplied;
(iii) the name of the drug, the quantity supplied, and strength of the drug distributed;
(iv) the directions for use;
(v) the prescriber's name. The record shall include the name of the practitioner and, if involved,
the name of either the physician's assistant (PA) or the advanced registered nurse practitioner (ARNP);
(vi) the expiration date of the drug; and
(vii) the lot number of the drug.
(2) A supply of drugs shall be provided to a patient by a designated registered professional nurse or
nurses pursuant to a prescriber's order. Only a designated registered professional nurse or nurses may
access the pharmacy area and remove the supply of the drugs. The supply shall conform with the
following labeling requirements:
(A) The name, address, and telephone number of the health department or family planning clinic
from which the drug is supplied;
(B) the full name of the patient;
(C) adequate directions for use of the drug;
(D) the name of the prescriber. The label shall include the name of the practitioner and, if
involved, the name of either the physician's assistant (PA) or the advanced registered nurse practitioner (ARNP);
(E) the date the supply was distributed;
(F) the identification number assigned to the supply of the drug distributed by the health
department or family planning clinic;
(G) the brand name or corresponding generic name of the drug;
(H) necessary auxiliary labels and storage instructions, if needed; and
(I) the beyond-use date of the drug issued.
(3) Repackaged drugs shall be packaged in suitable containers and shall be subject to all other
provisions of the Kansas state board of pharmacy rules and regulations under the pharmacy act of the
state of Kansas.
(d) The appointment of any Kansas licensed pharmacist as pharmacist-in-charge of a health department
or family planning clinic shall be subject to the provisions of K.A.R. 68-1-2a and 68-7-13.
(Authorized by and implementing K.S.A. 65-1648; effective, T-84-3, Feb. 10, 1983; effective May 1,
1984; amended July 23, 1999; amended April 28, 2000.)
68-7-19 Transfer of a refillable prescription between pharmacies.
(a) As used in K.S.A. 65-1656, and amendments thereto, the requested or transferring pharmacy is that pharmacy which has on file the original refillable prescription that the patient wishes to transfer to a second pharmacy. The dispensing or requesting pharmacy is the pharmacy that is wanting the information transferred from the original refillable prescription so that the patient may obtain the medication at this second pharmacy or the
pharmacy receiving the transferred prescription.
(b) Valid refillable prescriptions for prescription drugs not listed in schedule II of the uniform
controlled substances act may be transferred either by direct communications between two licensed
pharmacists from one pharmacy to another pharmacy or by a licensed pharmacist operating a suitable
electronic device. Before any prescription is transferred, the prescription information at the transferring
pharmacy shall meet all of the following criteria:
(1) The prescription information indicates authorization for refilling by the prescriber.
(2) The drug on the prescription information is not a schedule II controlled substance.
(3) The number of lawfully allowable refills directed by the prescriber has not been exceeded.
(4) The maximum allowable time limit from the original dating of the prescription has not been
exceeded.
(c) When a prescription on record is transferred, the following record keeping shall be required:
(1) (A) If the transfer involves a noncontrolled substance, the pharmacist at the transferring )pharmacy shall perform the following:
(i) Cancel the transferred prescription by writing the word "void" on its face; and
(ii) record on the face of the prescription the name and address of the pharmacy to which the prescription was transferred, the date of the transfer request, the full name of the pharmacist to which the prescription was transferred, and the full name of the pharmacist transferring the prescription.
(B) If the pharmacy from which the prescription is transferred utilizes a computerized prescription record-keeping system adequate to do so, the transferring pharmacist may record the information required by paragraphs (1)(A)(i) and (ii) in the computer record of the prescription instead
of recording the information on the face of the prescription.
(C) Transferring pharmacies that have computerized record-keeping systems that permit requesting pharmacies to electronically transfer prescriptions and prescription information from the transferring pharmacy to the requesting pharmacy shall establish procedures to permit these transfers only in instances of valid and legal requests and to insure that the prescription information required by subsection (b) is available to the requesting pharmacy at the time of the electronic transfer.
(D) If the requesting pharmacy is transferring a prescription and prescription information from another pharmacy without communicating directly with a pharmacist at the transferring pharmacy, the pharmacist at the requesting pharmacy shall insure that there is a sufficient electronic record left at the transferring pharmacy so that a pharmacist at the transferring pharmacy can comply with the recordkeeping requirements of K.S.A. 65-1656, and amendments thereto, and these regulations.
(2) (A) If the transfer involves a C-III, IV, or V controlled substance, the pharmacist at the transferring pharmacy shall perform the following:
(i) Cancel the transferred prescription by writing the word "void" on its face; and
(ii) record on the back of the prescription the name, address, and DEA registration number of the pharmacy to which the prescription was transferred, the date of the transfer request, the full name of the pharmacist to which the prescription was transferred, and the full name of the pharmacist transferring the prescription.
(B) Transferring pharmacies that have computerized prescription record-keeping systems that permit requesting pharmacies to electronically transfer prescriptions and prescription information from the transferring pharmacy to the requesting pharmacy shall establish procedures to permit these
transfers only in instances of valid and legal requests and to insure that the prescription information required by subsection (b) is available to the pharmacist at the requesting pharmacy at the time of the electronic transfer.
(C) If the requesting pharmacy is transferring a prescription and prescription information from another pharmacy without communicating directly with a pharmacist at the transferring pharmacy, the pharmacist at the requesting pharmacy shall insure that there is a sufficient electronic record left at the transferring pharmacy so that a pharmacist at the transferring pharmacy can comply with the recordkeeping requirements of K.S.A. 65-1656, and amendments thereto, and these regulations.
(3) The prescription record at the pharmacy receiving the transferred prescription shall show the following, in addition to all other lawfully required information of an original prescription:
(A) The word "transfer" written on the face of the prescription record;
(B) the date of original issuance and the date of original filling, if different from the issuance date;
(C) the original number of refills authorized, the number of remaining authorized refills, and the date of last refill;
(D) the original prescription number;
(E) the name, address, and telephone number of the transferring pharmacy, and the name of the transferring pharmacist;
(F) the name, address, and telephone number of the prescriber; and
(G) if the transfer involves a C-III, IV, or V controlled substance, the DEA registration number of the prescriber and of the transferring pharmacy.
(4) If the transfer involves a noncontrolled substance and the pharmacy to which the prescription is transferred utilizes a computerized prescription record-keeping system adequate to do so, the receiving pharmacist may record the information required by paragraphs (3)(A) through (F) in the computer record of the prescription instead of otherwise recording the information.
(d) If two or more pharmacies use common electronic prescription files to maintain dispensing information and do not physically transfer prescriptions or information for dispensing purposes, all pharmacies licensed by the board that have access to these common files shall be responsible to insure that at all times the common files contain at least the following information readily available to any person accessing the file:
(1) Any authorization for refilling by the prescriber;
(2) an indication of whether or not the number of lawfully allowable refills authorized by the prescriber has been exceeded;
(3) an indication of whether or not the maximum allowable time limit from the original date of the prescription has been exceeded;
(4) any other information provided by the original prescription or prescription order; and
(5) the name and address of the pharmacy last dispensing the drug pursuant to the prescription.
(e) The dispensing pharmacy shall advise the patient and notify the transferring pharmacy that the original prescription shall be canceled in the transferring pharmacy.
(f) A Kansas pharmacist may transfer a valid, refillable prescription from or to another pharmacy in or outside the state of Kansas. Noncontrolled substance prescriptions may be transferred more than once, but C-III, IV, and V controlled substance prescriptions shall not be transferred more than one time.
(Authorized by and implementing K.S.A. 1998 Supp. 65-1656; effective March 29, 1993; amended
July 23, 1999.)
68-7-20 Shared services.
(a) (1) "Order" means either of the following:
(A) A prescription order as defined in K.S.A. 65-1626 and amendments thereto; or
(B) a medication order as defined in K.A.R. 68-5-1.
(2) "Shared order filling" means the following:
(A) Preparing, packaging, compounding, or labeling an order, or any combination of these functions, by a person authorized by the pharmacy act to do so and located at a pharmacy on behalf of and at the request of another pharmacy; and
(B) returning the filled order to the requesting pharmacy for delivery to the patient or patient's agent or, at the request of the requesting pharmacy, directly delivering the filled order to the patient.
(3) "Shared order processing" means the following order processing functions that are performed by a person authorized by the pharmacy act and located at a pharmacy, on behalf of and at the request of another pharmacy:
(A) Interpreting and entering the order; and
(B) performing drug utilization reviews, claims adjudication, refill authorizations, or therapeutic interventions, or any combination of these functions.
(4) "Shared services" means shared order filling or shared order processing, or both.
(b) Each pharmacy participating in shared services shall be registered by the board as either a resident or a non-resident pharmacy.
(c) Pharmacies may provide or utilize shared services functions only if the pharmacies involved meet the following requirements:
(1) Share a common electronic file or appropriate technology to allow access to sufficient information necessary to fill, refill, or perform shared services in conformance with the pharmacy act and the board's regulations; and
(2) (A) Have the same owner; or
(B) have a written contract outlining the services provided and the shared responsibilities of each party in complying with the pharmacy act and the board's regulations.
(d) Pharmacies engaged in shared services shall meet the following requirements:
(1) Maintain records identifying, individually for each order processed, the name of each pharmacist, technician, pharmacy student, and intern who took part in the drug utilization review, refill authorization, or therapeutic intervention functions performed at that pharmacy;
(2) maintain records identifying, individually for each order filled or dispensed, the name of each pharmacist, technician, pharmacy student, and intern who took part in the filling, dispensing, and counseling functions performed at that pharmacy;
(3) report to the board as soon as practical the results of any disciplinary action taken by another state's pharmacy board involving shared services;
(4) maintain a mechanism for tracking the order during each step of the processing and filling procedures performed at the pharmacy;
(5) maintain a mechanism to identify on the prescription label all pharmacies involved in filling the
(6) provide for adequate security to protect the confidentiality and integrity of patient information;
and
(7) be able to obtain for inspection any required record or information within 72 hours of any request by a board representative.
(e) Each pharmacy providing or utilizing shared services shall adopt and maintain a joint policies and procedures manual that meets both of the following criteria:
(1) The manual describes how compliance with the pharmacy act and the board's regulations will be accomplished while engaging in shared services.
(2) A copy of the manual is maintained in each pharmacy.
(f) Nothing in this regulation shall prohibit an individual pharmacist licensed in Kansas who is an employee of or under contract with the pharmacy from accessing the pharmacy’s electronic database from inside or outside the pharmacy and performing the order processing functions permitted by the pharmacy act, if both of the following conditions are met:
(1) The pharmacy establishes controls to protect the privacy and security of confidential records.
(2) None of the database is duplicated, downloaded, or removed from the pharmacy's electronic database.
(Authorized by K.S.A. 65-1630 and 65-1656; implementing K.S.A. 65- 1626(cc), 65-1626a, 65-1637, 65-1642, and 65-1656; effective April 16, 2004.)
68-7-21 Institutional Drug Rooms.
(a) All prescription-only drugs dispensed or administered from an
institutional drug room shall be in prepackaged units, the original manufacturer's bulk packaging, or patient-specific pharmacy labeled packaging. All prepackaging shall meet the requirements of K.A.R. 68-7-15.
(b) Each pharmacist of practitioner, as that term is defined in K.S.A. 65-1637a and amendments thereto; who is responsible for supervising an institutional drug room shall perform the following:
(1) Develop or approve programs for the training and supervision of all personnel in the providing and control of drugs;
(2) develop or approve a written manual of policies and procedures governing the storage, control, and provision of drugs when a pharmacist or practitioner is not on duty;
(3) maintain documentation of at least quarterly reviews of drug records, drug storage conditions, and the drugs stored in all locations within the institutional drug room;
(4) develop or approve written procedures for documenting all reportable incidents, as defined in K.A. R. 68-7-12b, and documenting the steps taken to avoid a repeat of each reportable incident.
(c) The policies and procedures governing the storage, control, and provision of drugs in an
institutional drug room when a pharmacist or practitioner is not on duty shall include the following requirements:
(1) A record of all drugs provided to each patient from the institutional drug room shall be maintained in the patient's file and shall include the practitioner's order or written protocol.
(2) If the practitioner's order was given orally, electronically, or by telephone, the order shall be recorded, either manually or electronically. The recorded copy of the order shall include the name of the person who created the recorded copy and shall be maintained as part of the permanent patient file.
(3) The records maintained in each patient's file shall include the following information:
(A) The full name of the patient;
(B) the date on which the drug was provided;
(C) the name of the drug, the quantity provided, and the strength of the drug provided;
(D) the directions for use of the drug; and
(E) the prescriber's name and, if the prescriber is a physician's assistant or advanced registered nurse practitioner, the name of that person's supervising practitioner.
(d) All drugs dispensed from an institutional drug room for use outside the institution shall be in a container or package that contains a label bearing the following information:
(1) The patient's name
(2) the identification number assigned to the drug provided;
(3) the brand name or corresponding generic name of the drug, the strength of the drug, and either the name of the manufacturer or an easily identified abbreviation of the manufacturer's name;
(4) any necessary auxiliary labels and storage instructions;
(5) the beyond-use date of the drug provided;
(6) the instructions for use; and
(7) the name of the institutional drug room.
(e) Each label for any prepackaged or repackaged drug shall meet the requirements of K.A.R. 68-7-16.
(Authorized by K.S.A. 65-1630 and K.S.A. 65-1637a; implementing K.S.A. 2008 Supp. 65-1626, K.S.A. 2008 Supp. 65-1626d, and K.S.A. 65-1637a; effective April 2010.)